Correlation Between Centessa Pharmaceuticals and RF Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and RF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and RF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and RF Acquisition Corp, you can compare the effects of market volatilities on Centessa Pharmaceuticals and RF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of RF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and RF Acquisition.

Diversification Opportunities for Centessa Pharmaceuticals and RF Acquisition

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Centessa and RFACR is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and RF Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RF Acquisition Corp and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with RF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RF Acquisition Corp has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and RF Acquisition go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and RF Acquisition

Given the investment horizon of 90 days Centessa Pharmaceuticals is expected to generate 93.8 times less return on investment than RF Acquisition. But when comparing it to its historical volatility, Centessa Pharmaceuticals PLC is 45.4 times less risky than RF Acquisition. It trades about 0.1 of its potential returns per unit of risk. RF Acquisition Corp is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  8.01  in RF Acquisition Corp on September 14, 2024 and sell it today you would earn a total of  5.99  from holding RF Acquisition Corp or generate 74.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy37.65%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  RF Acquisition Corp

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Centessa Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
RF Acquisition Corp 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RF Acquisition Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain fundamental indicators, RF Acquisition reported solid returns over the last few months and may actually be approaching a breakup point.

Centessa Pharmaceuticals and RF Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and RF Acquisition

The main advantage of trading using opposite Centessa Pharmaceuticals and RF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, RF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RF Acquisition will offset losses from the drop in RF Acquisition's long position.
The idea behind Centessa Pharmaceuticals PLC and RF Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk